Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_assertion type Assertion NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_head.
- NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_provenance.
- NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_assertion evidence source_evidence_literature NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_provenance.
- NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_assertion SIO_000772 25060991 NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_provenance.
- NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_assertion wasDerivedFrom befree-20150227 NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_provenance.
- NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_assertion wasGeneratedBy ECO_0000203 NP621166.RAdmbTz9BiVc6B78pdjiwBvfqhCHlLoYXvqLMF0lFuGOg130_provenance.